Insights

Dr Phillip Fleshner reviews the complexities of medical and surgical treatment for perianal and fistulizing Crohn disease.

Dr Loftus, from the Mayo Clinic in Rochester, Minnesota, reviews his poster presentation from the recent American College of Gastroenterology meeting on health-related quality of life among patients with Crohn disease treated with ustekinumab...

Corey Siegel, MD, and Jessica Salwen-Deremer, PhD, from Dartmouth-Hitchcock Medical Center, discuss the prevalence of sleep disturbances and insomnia among patients with inflammatory bowel disease, and how cognitive behavioral therapy can...

In this video, Dr Barnes discusses the highlights from his presentation on Emerging Management of Disorders of the Pouch from the Advances in Inflammatory Bowel Disease regional meeting on September 25.

In this podcast, Maia Kayal, MD, from the Icahn School of Medicine at Mount Sinai in New York City, discusses her recent research into whether using the same biologic therapy before and after total proctocolectomy with ileal pouch anal...

In this episode of IBD Drive Time, Dr Raymond Cross from the IBD Center at the University of Maryland and Dr Ben Click from the Cleveland Clinic review “best of” abstracts on inflammatory bowel disease from United European Gastroenterology...

Dr Charabaty, from Johns Hopkins School of Medicine, discusses the poster presentation on the study of safety of ustekinumab among patients aged 60 years and older with inflammatory disease, which was shown at the recent American College of...

Dr Horst, from Vanderbilt University, reviews the results a study of how a delay of more than 14 days in escalating dosage of biologic treatment can affect outcomes for patients with IBD.

Dr Christina Ha, from Cedars-Sinai, moderated a discussion at the ACG Scientific Meeting with Dr Raymond Cross, from the University of Maryland, and Dr Bincy Abraham, from Houston Methodist, about beginning IBD therapy, changing therapeutic...